Alembic Pharma receives USFDA Final Approval for Erlotinib Tablets, 25 mg, 100 mg, and 150 mg
Mumbai, Jul 9: Pharma major Alembic Pharma Today said that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Erlotinib Tablets, 25 mg,…